Arista-Nasr J, González-Romo M A, Mantilla-Morales A, Lazos-Ochoa M, Ortiz-Hidalgo C
Department of Pathology, Instituto Nacional de la Nutricion, Salvador Zubiran, Mexico City, Mexico.
J Clin Gastroenterol. 1994 Jan;18(1):67-71. doi: 10.1097/00004836-199401000-00016.
The clinicopathologic findings in eight Mexican patients with immunoproliferative small intestinal disease (IPSID) are analyzed. Four of these cases have been previously reported and the remainder were found in a retrospective review of 42 lymphoproliferative disorders of the small bowel (9.5% of the cases at our institution). There were six male and two female patients with an average age of 30 years. Laparotomy with intestinal resection was performed in seven cases. Malignant lymphoma was documented in five and the early phase of IPSID in two patients. The remaining case was diagnosed by means of several endoscopic biopsies. It is concluded that although IPSID seems to be a rare disease in the mestizo population of our country, it may not be exceptional and its diagnosis has probably been overlooked.
分析了8例墨西哥免疫增殖性小肠疾病(IPSID)患者的临床病理特征。其中4例此前已有报道,其余病例是在对42例小肠淋巴增殖性疾病进行回顾性研究时发现的(占我院病例的9.5%)。患者中有6名男性和2名女性,平均年龄为30岁。7例患者接受了剖腹肠切除术。5例确诊为恶性淋巴瘤,2例为IPSID早期。其余1例通过多次内镜活检确诊。结论是,尽管IPSID在我国混血人群中似乎是一种罕见疾病,但可能并非罕见,其诊断可能被忽视了。